Home›Companies›Biotech & Pharma›Evida Biosciences

Evida Biosciences Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 11, 2024·Suggest an edit

About Evida Biosciences

Evida Biosciences is a private company based in San Diego, California, incorporated in 2024 in Delaware. It has reported $42,000,000 raised in one offering on Form D since October 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 25, 2024Oct 11, 2024$42,000,000fully sold26$1.6MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Evida Biosciences's Form D filed Oct 11, 2024.

SG
Scott Glenn
Director
Also a director at GLO Pharma and Mirador Therapeutics.
MW
Michael Walsh
President, Secretary and Chief Financial Officer, director
Also a director at SRT Therapeutics.
LO
Lauren Otsuki
Director
Also an executive officer and director at GLO Pharma and a president and chief executive officer, director at SRT Therapeutics.
RB
Rolf Benirschke
Director
Also a director at SRT Therapeutics.
SW
Shierley Widjaja
Director
Also a director at SRT Therapeutics.
DW
BD
Brian Feagan, M.D.
Director
Also a director at SRT Therapeutics.

Sources

  1. SECEvida Biosciences Inc. filing history